PFSA profusa.com Market Cap to Net Assets Ratio

Profusa Inc (PFSA) develops innovative muscle oxygen sensors based on biocompatible gels, yet export restrictions and component shortages are hindering expansion into global markets, where the metric stands at 0.00. This share price chart visualizes market expectations while management finalizes the efficiency verification of wearable systems to obtain regulatory approvals, upon which further investor confidence depends.

PFSA Profusa, Inc: Market Value to Book Value in the range 07/15/2025 - 10/27/2026

The indicator is calculated as the quotient of the company's market value divided by its reported net equity. This metric reveals the gap between stock market expectations and the business's actual assets. For Profusa Inc (PFSA), this gap is driven by the high value of patents for biochemical sensors. It is critical for investors to compare the current market capitalization-to-book value ratio with historical peaks to avoid overpaying for the future monetization of medical technologies.

Competitor analysis

DXCM: Market Capitalization to Book Value Ratio|Market Capitalization to Book Value Ratio penumbrainc.com|Novanta (NOVT) - Market Cap to Net Assets Ratio|Market Cap to Book Value Multiple Haemonetics Corp|Inspire Sleep (INSP) - Market Capitalization to Book Value Ratio|Market Value to Book Value Procept (PRCT)|CNMD: Market Capitalization to Book Value Ratio|pulsebiosciences.com - Market-to-Book Ratio|Market Value to Book Value Ratio InMode (INMD)|PMI - Market Value to Book Value|SRDX: Market Capitalization to Book Value Ratio|SENS (Senseonics Holdings, Inc.) - Market Capitalization to Book Value Ratio|Market Value to Book Value Ratio NeuroPace, Inc. NPCE|Market Capitalization to Net Assets Tactile Systems Technology Inc.|SANUWAVE - Market Capitalization to Book Value Ratio|Market-to-Book Ratio Outset Medical Inc OM|Market Cap to Net Assets Ratio ELMD (Electromed)|LNSR - Market Capitalization to Book Value Ratio|Market Cap to Net Assets Ratio AVITA Medical, Inc. RCEL|PROF - Market Cap to Book Value Multiple|bairdmed.com - Market Capitalization to Book Value Ratio|EDAP TMS (EDAP) - Market Capitalization to Book Value|Market Capitalization to Book Value Ratio APYX|Market Cap to Net Assets Ratio IceCure Medical, Ltd. (ICCM)|Pulmonx Corporation (LUNG) - Market Cap to Net Assets Ratio|Market Value to Book Value TELA (telabio.com)|CytoSorbents Corporation - Market Value to Book Value Ratio|Market Cap to Net Assets Ratio Sensus Healthcare Inc SRTS|ZYXI (Zynex Inc) - Market Capitalization to Book Value Ratio|ECOR - Market-to-Book Ratio|Market Capitalization to Book Value Ratio vicarioussurgical.com|Inspira Technologies (IINN) - Capitalization to Book Value Ratio|ICU: Market Capitalization to Book Value Ratio|Market Capitalization to Book Value IRIDEX Corp.|Market Capitalization to Book Value Ratio INBS (Intelligent Bio Solutions)|Market Cap to Net Assets Ratio beyondair.net (XAIR)|Market Capitalization to Book Value Ratio SSKN (STRATA Skin Sciences, Inc.)|GlucoTrack Inc. - Market Capitalization to Book Value Ratio|NAOV - Market Value to Book Value Ratio|Venus Concept Inc (VERO) - Market Value to Book Value Ratio|Market Cap to Net Assets Ratio CHF Solutions NUWE|Aethlon Medical Corp (AEMD) - Market Value to Book Value|Market Capitalization to Book Value Ratio ASXC (Asensus Surgical Inc)|Market-to-Book Ratio AVGR|BSGM: Market Value to Book Value Ratio|Market Value to Equity Ratio Cutera Inc. CUTR|Market Cap to Net Assets Ratio KNW (Know Labs Corp)|Market Capitalization to Book Value Ratio Inari Medical Corp NARI|Market Capitalization to Book Value Ratio NVRO (Nevro Corp.)|RSLS: Market Capitalization to Book Value|Market Value to Book Value Ratio Silk Road Medical (SILK)